Mark S. Link

52.3k total citations · 19 hit papers
315 papers, 22.2k citations indexed

About

Mark S. Link is a scholar working on Cardiology and Cardiovascular Medicine, Emergency Medicine and Surgery. According to data from OpenAlex, Mark S. Link has authored 315 papers receiving a total of 22.2k indexed citations (citations by other indexed papers that have themselves been cited), including 263 papers in Cardiology and Cardiovascular Medicine, 92 papers in Emergency Medicine and 59 papers in Surgery. Recurrent topics in Mark S. Link's work include Cardiovascular Effects of Exercise (122 papers), Cardiac electrophysiology and arrhythmias (101 papers) and Cardiac Arrhythmias and Treatments (97 papers). Mark S. Link is often cited by papers focused on Cardiovascular Effects of Exercise (122 papers), Cardiac electrophysiology and arrhythmias (101 papers) and Cardiac Arrhythmias and Treatments (97 papers). Mark S. Link collaborates with scholars based in United States, Italy and Canada. Mark S. Link's co-authors include Barry J. Maron, N.A. Mark Estes, Martin S. Maron, James E. Udelson, Steve R. Ommen, Paul J. Wang, Clyde W. Yancy, Robert O. Bonow, Rick A. Nishimura and Jeffrey A. Towbin and has published in prestigious journals such as New England Journal of Medicine, JAMA and Circulation.

In The Last Decade

Mark S. Link

301 papers receiving 21.3k citations

Hit Papers

2011 ACCF/AHA Guideline for the Diagnosis and Trea... 2000 2026 2008 2017 2011 2010 2011 2015 2020 500 1000 1.5k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. 2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy
    2011 1.6k citations Barry J. Maron, Mark S. Link et al. Circulation profile →
  2. Part 8: Adult Advanced Cardiovascular Life Support
    2010 1.1k citations Mark S. Link et al. Circulation profile →
  3. 2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy
    2011 869 citations Barry J. Maron, Mark S. Link et al. Journal of the American College of Cardiology profile →
  4. Part 7: Adult Advanced Cardiovascular Life Support
    2015 811 citations Mark S. Link et al. Circulation profile →
  5. 2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy: Executive Summary
    2020 727 citations José A. Joglar, Mark S. Link et al. Journal of the American College of Cardiology profile →
  6. Hypertrophic Cardiomyopathy Is Predominantly a Disease of Left Ventricular Outflow Tract Obstruction
    2006 692 citations Martin S. Maron, Iacopo Olivotto et al. Circulation profile →
  7. Exercise and Acute Cardiovascular Events
    2007 679 citations Domenico Corrado, N.A. Mark Estes et al. Circulation profile →
  8. Efficacy of Implantable Cardioverter–Defibrillators for the Prevention of Sudden Death in Patients with Hypertrophic Cardiomyopathy
    2000 661 citations Barry J. Maron, Mark S. Link et al. profile →
  9. 2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy: Executive Summary
    2011 585 citations Barry J. Maron, Mark S. Link et al. Circulation profile →
  10. 2012 ACCF/AHA/HRS Focused Update Incorporated Into the ACCF/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities
    2012 481 citations N.A. Mark Estes, Mark S. Link et al. Journal of the American College of Cardiology profile →
  11. Arrhythmogenic Right Ventricular Cardiomyopathy
    2017 444 citations Domenico Corrado, Mark S. Link et al. profile →
  12. 2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy
    2020 408 citations José A. Joglar, Mark S. Link et al. Journal of the American College of Cardiology profile →
  13. 2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy
    2020 376 citations José A. Joglar, Mark S. Link et al. Circulation profile →
  14. 2017 ACC/AHA/HRS guideline for the evaluation and management of patients with syncope
    2017 316 citations Robert S. Sheldon, David G. Benditt et al. profile →
  15. 2017 ACC/AHA/HRS Guideline for the Evaluation and Management of Patients With Syncope: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society
    2017 310 citations Robert S. Sheldon, David G. Benditt et al. Circulation profile →
  16. Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 3: Hypertrophic Cardiomyopathy, Arrhythmogenic Right Ventricular Cardiomyopathy and Other Cardiomyopathies, and Myocarditis
    2015 301 citations Barry J. Maron, James E. Udelson et al. Circulation profile →
  17. 2017 ACC/AHA/HRS Guideline for the Evaluation and Management of Patients With Syncope: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society
    2017 253 citations Win‐Kuang Shen, Robert S. Sheldon et al. Circulation profile →
  18. 2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy: Executive Summary
    2020 201 citations José A. Joglar, Mark S. Link et al. Circulation profile →
  19. 2024 HRS expert consensus statement on arrhythmias in the athlete: Evaluation, treatment, and return to play
    2024 44 citations Rachel Lampert, Michael J. Ackerman et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark S. Link United States 69 17.2k 4.7k 4.2k 1.9k 1.3k 315 22.2k
Xavier Jouven France 59 6.3k 0.4× 3.0k 0.7× 2.7k 0.6× 1.8k 1.0× 620 0.5× 247 14.0k
Christian Hassager Denmark 67 6.3k 0.4× 4.7k 1.0× 2.9k 0.7× 2.5k 1.4× 1.2k 0.9× 618 16.9k
Massimo Piepoli Italy 74 16.6k 1.0× 738 0.2× 2.3k 0.5× 1.6k 0.8× 879 0.7× 349 21.6k
Wojciech Zaręba United States 83 30.5k 1.8× 849 0.2× 3.1k 0.7× 598 0.3× 5.8k 4.4× 625 34.2k
Dick H. J. Thijssen Netherlands 62 8.8k 0.5× 733 0.2× 1.6k 0.4× 582 0.3× 743 0.6× 351 14.8k
Éloi Marijon France 45 5.0k 0.3× 2.2k 0.5× 1.2k 0.3× 1.6k 0.9× 365 0.3× 304 9.0k
Sumeet S. Chugh United States 51 10.3k 0.6× 2.0k 0.4× 1.2k 0.3× 1.3k 0.7× 1.0k 0.8× 218 13.8k
Jerome L. Fleg United States 78 16.5k 1.0× 391 0.1× 3.2k 0.8× 1.2k 0.7× 1.2k 0.9× 323 25.5k
Johan Herlitz Sweden 71 10.3k 0.6× 11.3k 2.4× 4.0k 0.9× 2.5k 1.3× 818 0.6× 581 22.9k
Joseph F. Polak United States 78 14.8k 0.9× 875 0.2× 5.0k 1.2× 4.3k 2.3× 1.3k 1.0× 319 26.4k

Countries citing papers authored by Mark S. Link

Since Specialization
Citations

This map shows the geographic impact of Mark S. Link's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark S. Link with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark S. Link more than expected).

Fields of papers citing papers by Mark S. Link

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark S. Link. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark S. Link. The network helps show where Mark S. Link may publish in the future.

Co-authorship network of co-authors of Mark S. Link

This figure shows the co-authorship network connecting the top 25 collaborators of Mark S. Link. A scholar is included among the top collaborators of Mark S. Link based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark S. Link. Mark S. Link is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Abdelfattah, Omar, et al.. (2025). Global and Temporal Trends in Utilization and Outcomes of Implantable Cardioverter Defibrillators in Hypertrophic Cardiomyopathy. Circulation Arrhythmia and Electrophysiology. 18(2). e013479–e013479.
2.
Gray, Belinda, Michael J. Ackerman, Mark S. Link, & Rachel Lampert. (2024). Vigorous exercise and sports participation in individuals with hypertrophic cardiomyopathy. Trends in Cardiovascular Medicine. 35(2). 116–123. 1 indexed citations
3.
Link, Mark S., et al.. (2024). Omega-3 Fatty Acids and Arrhythmias. Circulation. 150(6). 488–503. 4 indexed citations
4.
Luni, Faraz Khan, James Daniels, Mark S. Link, et al.. (2020). Meta-analysis of Usefulness of Phrenic Nerve Stimulation in Central Sleep Apnea. The American Journal of Cardiology. 125(11). 1738–1744. 3 indexed citations
5.
Link, Mark S., Joel Schwartz, Heike Luttmann‐Gibson, et al.. (2020). Exposure to Air Pollution and Particle Radioactivity With the Risk of Ventricular Arrhythmias. Circulation. 142(9). 858–867. 24 indexed citations
6.
Maron, Martin S., N.A. Mark Estes, Lori Lyn Price, et al.. (2019). Safety, Side Effects and Relative Efficacy of Medications for Rhythm Control of Atrial Fibrillation in Hypertrophic Cardiomyopathy. The American Journal of Cardiology. 123(11). 1859–1862. 23 indexed citations
7.
Luni, Faraz Khan, Talha Farid, Sonia Malik, et al.. (2019). Percutaneous left ventricular assist device support during ablation of ventricular tachycardia: A meta‐analysis of current evidence. Journal of Cardiovascular Electrophysiology. 30(6). 886–895. 9 indexed citations
8.
Khera, Rohan, et al.. (2017). Abstract 17130: Diagnostic and Prognostic Utility of Cardiac Troponin in Post-Cardiac Arrest Care. Circulation. 1 indexed citations
9.
Shen, Win‐Kuang, Robert S. Sheldon, David G. Benditt, et al.. (2017). 2017 ACC/AHA/HRS Guideline for the Evaluation and Management of Patients With Syncope: Executive Summary. Journal of the American College of Cardiology. 70(5). 620–663. 97 indexed citations
10.
11.
Rowin, Ethan J., Barry J. Maron, Iacopo Olivotto, et al.. (2013). Abstract 14979: Progressive Heart Failure is Uncommon in Patients With Nonobstructive Hypertrophic Cardiomyopathy. Circulation. 1 indexed citations
12.
Brenyo, Andrew, Mark S. Link, Alon Barsheshet, et al.. (2011). Cardiac Resynchronization Therapy Reduces Left Atrial Volume and the Risk of Atrial Tachyarrhythmias in MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial with Cardiac Resynchronization Therapy). Journal of the American College of Cardiology. 58(16). 1682–1689. 79 indexed citations
13.
Corrado, Domenico, Loira Leoni, Hugh Calkins, et al.. (2006). Abstract 2691: Prophylactic Implantable Defibrillator in Patients with Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia and No Prior Sustained Ventricular Tachyarrhythmias: Therapy-Based Risk Stratification During a Long Term Follow-up. Circulation. 114. 561–561. 1 indexed citations
14.
Rich, David Q., Murray A. Mittleman, Mark S. Link, et al.. (2005). Increased Risk of Paroxysmal Atrial Fibrillation Episodes Associated with Acute Increases in Ambient Air Pollution. Environmental Health Perspectives. 114(1). 120–123. 131 indexed citations
15.
Dockery, Douglas W., Heike Luttmann‐Gibson, David Q. Rich, et al.. (2005). Association of Air Pollution with Increased Incidence of Ventricular Tachyarrhythmias Recorded by Implanted Cardioverter Defibrillators. Environmental Health Perspectives. 113(6). 670–674. 217 indexed citations
16.
Pandian, Natesa G., et al.. (2004). Echocardiographic evidence of left atrial abnormality in young patients with lone paroxysmal atrial fibrillation. The American Journal of Cardiology. 94(4). 511–513. 34 indexed citations
17.
Greenfield, Ruth Ann, Ali Massumi, Mark S. Link, et al.. (2003). Use of the AutoCapture Pacing System with Implantable Defibrillator Leads. Pacing and Clinical Electrophysiology. 26(1p2). 471–473. 6 indexed citations
18.
Maron, Barry J., N.A. Mark Estes, & Mark S. Link. (2002). Emergency Treatment for Commotio Cordis—Reply. JAMA. 287(23). 3080–3080.
19.
Link, Mark S., Munther K. Homoud, Paul J. Wang, & N.A. Mark Estes. (2002). Syncope in athletes. 23(11). 625–632. 3 indexed citations
20.
Link, Mark S., et al.. (1998). Cardioverter-defibrillator implantation: Is it appropriate for patients with syncope of unknown origin?. Cardiology in Review. 15(3). 45–47. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xavier Jouven Breakdown of academic impact, for papers by Christian Hassager Breakdown of academic impact, for papers by Massimo Piepoli Breakdown of academic impact, for papers by Wojciech Zaręba Breakdown of academic impact, for papers by Dick H. J. Thijssen Breakdown of academic impact, for papers by Éloi Marijon Breakdown of academic impact, for papers by Sumeet S. Chugh Breakdown of academic impact, for papers by Jerome L. Fleg Breakdown of academic impact, for papers by Johan Herlitz Breakdown of academic impact, for papers by Joseph F. Polak
Rankless by CCL
2026